Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 374

1.

Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE.

Bertram L, Lange C, Mullin K, Parkinson M, Hsiao M, Hogan MF, Schjeide BM, Hooli B, Divito J, Ionita I, Jiang H, Laird N, Moscarillo T, Ohlsen KL, Elliott K, Wang X, Hu-Lince D, Ryder M, Murphy A, Wagner SL, Blacker D, Becker KD, Tanzi RE.

Am J Hum Genet. 2008 Nov;83(5):623-32. doi: 10.1016/j.ajhg.2008.10.008. Epub 2008 Oct 30.

2.

A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease.

Coon KD, Myers AJ, Craig DW, Webster JA, Pearson JV, Lince DH, Zismann VL, Beach TG, Leung D, Bryden L, Halperin RF, Marlowe L, Kaleem M, Walker DG, Ravid R, Heward CB, Rogers J, Papassotiropoulos A, Reiman EM, Hardy J, Stephan DA.

J Clin Psychiatry. 2007 Apr;68(4):613-8.

PMID:
17474819
3.

Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.

Herold C, Hooli BV, Mullin K, Liu T, Roehr JT, Mattheisen M, Parrado AR, Bertram L, Lange C, Tanzi RE.

Mol Psychiatry. 2016 Nov;21(11):1608-1612. doi: 10.1038/mp.2015.218. Epub 2016 Feb 2.

4.

APOE and other loci affect age-at-onset in Alzheimer's disease families with PS2 mutation.

Wijsman EM, Daw EW, Yu X, Steinbart EJ, Nochlin D, Bird TD, Schellenberg GD.

Am J Med Genet B Neuropsychiatr Genet. 2005 Jan 5;132B(1):14-20.

PMID:
15389756
5.

SNPing away at complex diseases: analysis of single-nucleotide polymorphisms around APOE in Alzheimer disease.

Martin ER, Lai EH, Gilbert JR, Rogala AR, Afshari AJ, Riley J, Finch KL, Stevens JF, Livak KJ, Slotterbeck BD, Slifer SH, Warren LL, Conneally PM, Schmechel DE, Purvis I, Pericak-Vance MA, Roses AD, Vance JM.

Am J Hum Genet. 2000 Aug;67(2):383-94. Epub 2000 Jun 21.

6.

Genome-wide association of familial late-onset Alzheimer's disease replicates BIN1 and CLU and nominates CUGBP2 in interaction with APOE.

Wijsman EM, Pankratz ND, Choi Y, Rothstein JH, Faber KM, Cheng R, Lee JH, Bird TD, Bennett DA, Diaz-Arrastia R, Goate AM, Farlow M, Ghetti B, Sweet RA, Foroud TM, Mayeux R; NIA-LOAD/NCRAD Family Study Group.

PLoS Genet. 2011 Feb;7(2):e1001308. doi: 10.1371/journal.pgen.1001308. Epub 2011 Feb 17.

7.

Dynamin-binding protein gene on chromosome 10q is associated with late-onset Alzheimer's disease.

Kuwano R, Miyashita A, Arai H, Asada T, Imagawa M, Shoji M, Higuchi S, Urakami K, Kakita A, Takahashi H, Tsukie T, Toyabe S, Akazawa K, Kanazawa I, Ihara Y; Japanese Genetic Study Consortium for Alzeheimer's Disease.

Hum Mol Genet. 2006 Jul 1;15(13):2170-82. Epub 2006 Jun 1.

PMID:
16740596
8.

Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12.

Pericak-Vance MA, Bass MP, Yamaoka LH, Gaskell PC, Scott WK, Terwedow HA, Menold MM, Conneally PM, Small GW, Vance JM, Saunders AM, Roses AD, Haines JL.

JAMA. 1997 Oct 15;278(15):1237-41.

PMID:
9333264
9.

Evidence for three loci modifying age-at-onset of Alzheimer's disease in early-onset PSEN2 families.

Marchani EE, Bird TD, Steinbart EJ, Rosenthal E, Yu CE, Schellenberg GD, Wijsman EM.

Am J Med Genet B Neuropsychiatr Genet. 2010 Jul;153B(5):1031-41. doi: 10.1002/ajmg.b.31072.

10.

Genome-wide association analysis of age-at-onset in Alzheimer's disease.

Kamboh MI, Barmada MM, Demirci FY, Minster RL, Carrasquillo MM, Pankratz VS, Younkin SG, Saykin AJ; Alzheimer's Disease Neuroimaging Initiative, Sweet RA, Feingold E, DeKosky ST, Lopez OL.

Mol Psychiatry. 2012 Dec;17(12):1340-6. doi: 10.1038/mp.2011.135. Epub 2011 Oct 18.

11.

The SIRT2 polymorphism rs10410544 and risk of Alzheimer's disease in two Caucasian case-control cohorts.

Polito L, Kehoe PG, Davin A, Benussi L, Ghidoni R, Binetti G, Quadri P, Lucca U, Tettamanti M, Clerici F, Bagnoli S, Galimberti D, Nacmias B, Sorbi S, Guaita A, Scarpini E, Mariani C, Forloni G, Albani D.

Alzheimers Dement. 2013 Jul;9(4):392-9. doi: 10.1016/j.jalz.2012.02.003. Epub 2012 May 30.

PMID:
22651940
12.

Alzheimer's disease: analyzing the missing heritability.

Ridge PG, Mukherjee S, Crane PK, Kauwe JS; Alzheimer’s Disease Genetics Consortium.

PLoS One. 2013 Nov 7;8(11):e79771. doi: 10.1371/journal.pone.0079771. eCollection 2013.

13.

Genome scan on Swedish Alzheimer's disease families.

Sillén A, Forsell C, Lilius L, Axelman K, Björk BF, Onkamo P, Kere J, Winblad B, Graff C.

Mol Psychiatry. 2006 Feb;11(2):182-6.

PMID:
16288313
14.

Genome-wide association study of Alzheimer's disease with psychotic symptoms.

Hollingworth P, Sweet R, Sims R, Harold D, Russo G, Abraham R, Stretton A, Jones N, Gerrish A, Chapman J, Ivanov D, Moskvina V, Lovestone S, Priotsi P, Lupton M, Brayne C, Gill M, Lawlor B, Lynch A, Craig D, McGuinness B, Johnston J, Holmes C, Livingston G, Bass NJ, Gurling H, McQuillin A; GERAD Consortium; National Institute on Aging Late-Onset Alzheimer's Disease Family Study Group, Holmans P, Jones L, Devlin B, Klei L, Barmada MM, Demirci FY, DeKosky ST, Lopez OL, Passmore P, Owen MJ, O'Donovan MC, Mayeux R, Kamboh MI, Williams J.

Mol Psychiatry. 2012 Dec;17(12):1316-27. doi: 10.1038/mp.2011.125. Epub 2011 Oct 18.

15.

PSEN1 polymorphisms alter the rate of cognitive decline in sporadic Alzheimer's disease patients.

Belbin O, Beaumont H, Warden D, Smith AD, Kalsheker N, Morgan K.

Neurobiol Aging. 2009 Dec;30(12):1992-9. doi: 10.1016/j.neurobiolaging.2008.02.013. Epub 2008 Apr 9.

PMID:
18403054
16.

Identification of novel quantitative traits-associated susceptibility loci for APOE ε 4 non-carriers of Alzheimer's disease.

Jiang S, Yang W, Qiu Y, Chen HZ; Alzheimer's Disease Neuroimaging Initiative (ADNI).

Curr Alzheimer Res. 2015;12(3):218-27.

PMID:
25731621
17.

Genetic studies on chromosome 12 in late-onset Alzheimer disease.

Wu WS, Holmans P, Wavrant-DeVrièze F, Shears S, Kehoe P, Crook R, Booth J, Williams N, Pérez-Tur J, Roehl K, Fenton I, Chartier-Harlin MC, Lovestone S, Williams J, Hutton M, Hardy J, Owen MJ, Goate A.

JAMA. 1998 Aug 19;280(7):619-22.

PMID:
9718053
18.

Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease: relation to apolipoprotein E polymorphism.

Lehtovirta M, Soininen H, Helisalmi S, Mannermaa A, Helkala EL, Hartikainen P, Hänninen T, Ryynänen M, Riekkinen PJ.

Neurology. 1996 Feb;46(2):413-9.

PMID:
8614504
19.

Genome-wide linkage analyses of non-Hispanic white families identify novel loci for familial late-onset Alzheimer's disease.

Kunkle BW, Jaworski J, Barral S, Vardarajan B, Beecham GW, Martin ER, Cantwell LS, Partch A, Bird TD, Raskind WH, DeStefano AL, Carney RM, Cuccaro M, Vance JM, Farrer LA, Goate AM, Foroud T, Mayeux RP, Schellenberg GD, Haines JL, Pericak-Vance MA.

Alzheimers Dement. 2016 Jan;12(1):2-10. doi: 10.1016/j.jalz.2015.05.020. Epub 2015 Sep 11.

20.

Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region.

Chartier-Harlin MC, Parfitt M, Legrain S, Pérez-Tur J, Brousseau T, Evans A, Berr C, Vidal O, Roques P, Gourlet V, et al.

Hum Mol Genet. 1994 Apr;3(4):569-74.

PMID:
8069300

Supplemental Content

Support Center